DexCom, Inc. (DXCM) Balance Sheet

NASDAQ: DXCMAssets, liabilities, debt and equity over 10 years.

DXCM balance sheet, 2025

December 31, 2025 · U.S. dollars

$6.34B assets = $3.59B liabilities + $2.75B equity

What it owns$6.34BCash & ST investments: $2.00B (31.5%)Cash & ST investments$2.00B · 32%Receivables: $1.29B (20.3%)Receivables$1.29B · 20%Inventory: $629.1M (9.9%)Inventory $629.1MOther current: $115.6M (1.8%)PP&E: $1.64B (25.8%)PP&E$1.64B · 26%Goodwill & intangibles: $95.0M (1.5%)LT investments: $218.0M (3.4%)Other non-current: $356.3M (5.6%)=How it is financed$6.34BCurrent liabilities: $2.14B (33.8%)Current liabilities$2.14B · 34%Long-term debt: $1.24B (19.6%)Long-term debt$1.24B · 20%Other LT liabilities: $210.5M (3.3%)Shareholders’ equity: $2.75B (43.3%)Shareholders’ equity$2.75B · 43%

Both columns are drawn to the same scale: what DXCM owns equals what it owes plus shareholders’ equity. Hover a block for its value.

DXCM financial health

Current ratio1.88
Comfortable · current assets cover current liabilities 1.88×
Debt / equity0.51
Moderate leverage · $0.51 of debt for each $1 of equity
Equity / assets43.3%
Equity-funded · of assets funded by shareholders
Cash / debt143.8%
Cash covers debt · cash & short-term investments vs total debt
Goodwill & intangibles1.5%
Mostly tangible · of total assets

Descriptive bands, not a rating. Fiscal 2025.

DXCM balance sheet trends, 2016–2025

DexCom, Inc. balance sheet trends
MetricTrendThenLatestChange
Total assets$402.8M2016$6.34B2025+35.8%/yr
Total liabilities$119.0M2016$3.59B2025+46.0%/yr
Shareholders’ equity$283.8M2016$2.75B2025+28.7%/yr
Cash & short-term investments$123.7M2016$2.00B2025+36.2%/yr
Total debt$45.1M2016$1.39B2025+46.4%/yr
Net cash (debt)$78.6M2016$609.0M2025+$530.4M
Working capital$177.6M2016$1.89B2025+$1.7B
Book value per share$0.852016$6.772025+26.0%/yr
Current ratio2.7320161.882025−0.85
Debt / equity0.1620160.512025+0.35
Shares outstanding334.4M2016405.5M2025+2.2%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

DXCM assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

DXCM liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

DXCM debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

DXCM balance sheet

DexCom, Inc. annual balance sheet
2025202420232022202120202019201820172016
Assets
Cash & short-term investments$2.00B$2.58B$2.72B$2.46B$2.73B$2.71B$1.53B$1.39B$548.6M$123.7M
Cash & equivalents$917.7M$606.1M$566.3M$642.3M$1.05B$817.6M$446.2M$1.14B$441.5M$94.5M
Short-term investments$1.08B$1.97B$2.16B$1.81B$1.68B$1.89B$1.09B$248.6M$107.1M$29.2M
Receivables$1.29B$1.03B$987.5M$752.2M$516.6M$428.5M$286.3M$226.7M$134.3M$101.7M
Inventory$629.1M$542.6M$559.6M$306.7M$357.3M$234.7M$119.8M$70.7M$45.2M$45.4M
Other current assets$115.6M$145.8M$154.7M$153.7M$79.3M$53.9M$30.0M$16.5M$16.6M$9.2M
Total current assets$4.03B$4.30B$4.43B$3.67B$3.68B$3.42B$1.97B$1.70B$744.7M$280.0M
Property, plant & equipment (net)$1.64B$1.40B$1.18B$1.14B$889.9M$608.6M$392.8M$183.1M$145.6M$109.4M
Goodwill & intangible assets$95.0M$126.2M$159.7M$199.0M$58.0M$40.7M$18.6M$18.7M$24.2M$11.5M
Long-term investments$218.0M$119.3M$38.5M$19.0M$0$0$0$0$14.4M$5.9M
Other non-current assets$356.3M$534.9M$455.9M$369.3M$301.0M$216.4M$14.2M$14.7M$0$0
Total assets$6.34B$6.48B$6.26B$5.39B$4.93B$4.29B$2.40B$1.92B$904.1M$402.8M
Liabilities
Accounts payable$344.3M$345.3M$276.4M$237.9M$189.4M$163.3M$102.3M$147.1M$87.2M$68.1M
Short-term debt$21.6M$1.23B$21.1M$793.1M$20.5M$16.5M$13.6M$11.7M$33.4M$39.1M
Deferred revenue$7.7M$8.0M$18.4M$10.1M$2.1M$2.2M$1.7M$2.9M$3.2M$900,000
Total current liabilities$2.14B$2.93B$1.56B$1.84B$720.8M$614.1M$360.2M$222.4M$138.9M$102.4M
Long-term debt$1.24B$1.24B$2.43B$1.20B$1.70B$1.67B$1.06B$1.01B$327.6M$6.0M
Lease obligations$148.8M$146.0M$159.8M$174.7M$119.1M$172.3M$100.4M$7.3M$6.7M—
Other long-term liabilities$210.5M$212.9M$205.7M$222.9M$467.7M$182.7M$92.5M$20.0M$18.2M$10.6M
Total liabilities$3.59B$4.38B$4.20B$3.26B$2.89B$2.46B$1.51B$1.25B$484.7M$119.0M
Shareholders' equity
Common stock & paid-in capital$400,000$400,000$400,000$400,000$400,000$100,000$100,000$100,000$1.09B$905.8M
Retained earnings (deficit)$2.43B$1.60B$1.02B$479.9M$138.7M−$202.1M−$695.7M−$798.9M−$671.8M−$621.0M
Treasury stock————−$206.2M−$100.0M−$100.0M−$100.0M$0$0
Accumulated other comprehensive income$115.0M−$8.0M−$16.7M−$11.6M$500,000$3.2M$2.3M$1.5M−$2.6M−$1.0M
Minority interest————————$0$0
Total shareholders' equity$2.75B$2.10B$2.07B$2.13B$2.04B$1.83B$882.6M$663.3M$419.4M$283.8M
Key figures
Total debt$1.39B$2.59B$2.59B$2.15B$2.16B$1.84B$1.16B$1.02B$361.0M$45.1M
Net cash (debt)$609.0M−$8.0M$130.1M$311.2M$573.3M$868.2M$373.2M$363.6M$187.6M$78.6M
Working capital$1.89B$1.37B$2.87B$1.83B$2.96B$2.81B$1.61B$1.48B$605.8M$177.6M
Tangible book value$2.65B$1.98B$1.91B$1.93B$1.98B$1.79B$864.0M$644.6M$395.2M$272.3M
Book value per share$6.77$5.09$4.86$4.99$4.76$4.68$2.39$1.88$1.21$0.85
Shares outstanding405.5M412.7M425.5M427.5M428.8M390.0M369.2M352.8M345.2M334.4M
Current ratio1.881.472.841.995.115.585.477.645.362.73
Quick ratio1.531.232.391.744.515.115.057.254.922.20
Debt / equity0.511.231.251.011.061.011.311.540.860.16
Equity / assets43.3%32.4%33.0%39.5%41.4%42.6%36.9%34.6%46.4%70.5%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed February 12, 2026); data from EODHD.

DXCM financial position

At the end of fiscal 2025 (December 31, 2025), DexCom had total assets of $6.3 billion (down 2.2% from a year earlier), total liabilities of $3.6 billion and shareholders' equity of $2.7 billion. It held $2.0 billion in cash and short-term investments against $1.4 billion of debt, a net cash position of $609.0 million. Its current ratio was 1.88. In the latest quarter (ended June 30, 2026) total assets were $6.5 billion and equity $2.6 billion.

Related: DXCM income statement, DXCM cash flow statement, DXCM key metrics. See the DXCM stock overview for the latest quote and news.

DXCM balance sheet FAQ

What are DexCom's total assets?

DexCom reported total assets of $6.3 billion at the end of fiscal 2025 (December 31, 2025), compared with $6.5 billion a year earlier.

How much debt does DexCom have?

DexCom had $1.4 billion of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.51.

How much cash does DexCom have?

DexCom held $2.0 billion in cash and short-term investments at the end of fiscal 2025; with $1.4 billion of debt that is net cash of $609.0 million.

What is DexCom's book value?

DexCom's shareholders' equity (book value) was $2.7 billion at the end of fiscal 2025, or $6.77 per share.

What is DexCom's current ratio?

DexCom had current assets of $4.0 billion and current liabilities of $2.1 billion, a current ratio of 1.88 (it can cover its short-term obligations).

How much goodwill does DexCom have?

DexCom carried $95.0 million of goodwill and intangible assets, 1.5% of total assets, at the end of fiscal 2025.

Medical Devices: balance sheet